More doctors are seeing success with hydroxychloroquine and Zinc Sulphate in treating coronavirus patients
As mainstream media continues to downplay the effectiveness of malaria drug hydroxychloroquine as an unproven drug, more doctors are reportedly seeing success with hydroxychloroquine and Zinc Sulphate in treating coronavirus patients. One of those doctors is Los Angeles, California-based doctor said he is seeing significant success in prescribing the malaria drug hydroxychloroquine in combination with zinc to treat patients with severe symptoms of COVID-19, according to a report from ABC News.
Dr. Anthony Cardillo, CEO of Mend Urgent Care, says “Every patient I’ve prescribed it to has been very, very ill and within 8 to 12 hours, they were basically symptom-free,” Cardillo said in an interview Sunday with KABC-TV. “So, clinically I am seeing a resolution.” He added that combining the drug with zinc has been the key to the success. The hydroxychloroquine, he said, “opens the zinc channel” allowing the zinc to enter the cell, which then “blocks the replication of cellular machinery.”
Dr. Anthony Cardillo, who is the CEO of Mend Urgent Care, which has locations in Sherman Oaks, Van Nuys and Burbank, said he has seen very promising results when prescribing hydroxychloroquine in combination with zinc for the most severely-ill COVID-19 patients. However, he said using hydroxychloroquine does not work.
Dr. Cardillo is not alone. Over the past two weeks, we also told you about other doctors who have seen positive results using a combination of hydroxychloroquine, Zinc and azithromycin. For example, Dr. Vladimir Zelenko, a board-certified family practitioner in New York, successfully treated 699 coronavirus patients using the same drug regimen. Also, results of the first 62 patient randomized clinical trial show hydroxychloroquine helps coronavirus patients improve. Dr. Marlow Hernandez, the CEO of Cano Health, also said he has found some preliminary early success with hydroxycholoquine among coronavirus patients in hospitals in Florida. “Hydroxychloroquine is an important weapon in our arsenal,” he said.
Hydroxychloroquine has long been used for treatment of malaria and conditions such as lupus and arthritis. On March 30, the FDA issued emergency use authorization of anti-malaria drug Hydroxychloroquine for treatment of coronavirus patients. The FDA is encouraging trials and has provided limited emergency authorization for its use to treat COVID-19 patients.
“Every patient I’ve prescribed it to has been very, very ill and within 8 to 12 hours, they were basically symptom-free,” Cardillo told Eyewitness News. “So clinically I am seeing a resolution.”
He said he has found it only works if combined with zinc. The drug, he said, opens a channel for the zinc to enter the cell and block virus replication. He added that the drug should not be prescribed for those who are presenting only mild symptoms, as there are concerns about shortages for patients with other conditions who need to take the drug on a regular basis.
“We have to be cautious and mindful that we don’t prescribe it for patients who have COVID who are well,” Cardillo said. “It should be reserved for people who are really sick, in the hospital or at home very sick, who need that medication. Otherwise we’re going to blow through our supply for patients that take it regularly for other disease processes.”